Selected article for: "active renal and lupus nephritis"
Author: Bharati, Joyita; Rathi, Manish; Ramachandran, Raja; Sharma, Aman; Nada, Ritambhra; Kohli, Harbir S.
Title: Managing Active Iupus Nephritis During COVID-19 Pandemic
  • Cord-id: rb07ihld
  • Document date: 2021_2_16
    • ID: rb07ihld
    Snippet: India is seeing a rapid rise in coronavirus disease-2019 (COVID-19). Immunosuppression is a possible risk factor for severe COVID-19, although their exact interaction is unclear. A total of 13 cases with active lupus nephritis (LN, with or without extra-renal manifestations) were managed with intense immunosuppression between January 2020 and June 2020 during the COVID-19 pandemic at our center. There were no other comorbidities in any patient. All patients received hydroxychloroquine as a part
    Document: India is seeing a rapid rise in coronavirus disease-2019 (COVID-19). Immunosuppression is a possible risk factor for severe COVID-19, although their exact interaction is unclear. A total of 13 cases with active lupus nephritis (LN, with or without extra-renal manifestations) were managed with intense immunosuppression between January 2020 and June 2020 during the COVID-19 pandemic at our center. There were no other comorbidities in any patient. All patients received hydroxychloroquine as a part of standard of care. Vigorous precautionary measures were taken for preventing infection in all. One patient developed acute respiratory distress syndrome but was tested negative for COVID-19. None of the other 12 patients developed symptoms suggestive of COVID-19. We report safe management of patients with active LN with intense immunosuppression along with vigorous precautions amidst the COVID-19 pandemic. The role of hydroxychloroquine along with timely precautions needs to be further explored as protective measures against COVID-19 among systemic lupus erythematosus patients.

    Search related documents:
    Co phrase search for related documents
    • active case and ln lupus nephritis: 1
    • active case and ln patient: 1
    • active case and lung disease: 1, 2
    • active case and lupus nephritis: 1
    • acute respiratory distress and lung characterize: 1, 2
    • acute respiratory distress and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory distress and lupus nephritis: 1, 2
    • ln lupus nephritis and ln patient: 1
    • ln lupus nephritis and lung disease: 1, 2
    • ln lupus nephritis and lupus erythematosus: 1, 2, 3, 4, 5, 6
    • ln lupus nephritis and lupus nephritis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ln patient and lupus nephritis: 1
    • lung disease and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18